We are live on ! Find out more
PWM

Palumbo Wealth Management Portfolio holdings

AUM $410M
1-Year Est. Return 32.56%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.56%
3 Year Est. Return
+80.66%
5 Year Est. Return
+99.66%
10 Year Est. Return
AUM
$323M
AUM Growth
+$23.7M
Cap. Flow
+$5.97M
Cap. Flow %
1.85%
Top 10 Hldgs %
39.92%
Holding
212
New
25
Increased
92
Reduced
73
Closed
15

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$2.19M
2
IBIT icon
iShares Bitcoin Trust
IBIT
+$1.55M
3
NPCE icon
Neuropace
NPCE
+$1.55M
4
AMD icon
Advanced Micro Devices
AMD
+$1.08M
5
NVDA icon
NVIDIA
NVDA
+$974K

Sector Composition

Rank Sector Weight
1 Technology 17.36%
2 Healthcare 7.62%
3 Consumer Discretionary 7.61%
4 Financials 7.34%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SANA icon
176
Sana Biotechnology
SANA
$871M
$221K 0.07%
+81,093
New +$167K
AGG icon
177
iShares Core US Aggregate Bond ETF
AGG
$137B
$216K 0.07%
+2,180
New +$214K
QS icon
178
QuantumScape Corp
QS
$3.21B
$215K 0.07%
32,000
+544
+2% +$2.3K
SMH icon
179
VanEck Semiconductor ETF
SMH
$65.2B
$212K 0.07%
+759
New +$176K
UFOX
180
Defiance Space and Connective Tech ETF
UFOX
$835M
$211K 0.07%
+4,000
New +$180K
TWLO icon
181
Twilio
TWLO
$30B
$208K 0.06%
+1,676
New +$178K
PLD icon
182
Prologis
PLD
$135B
$208K 0.06%
1,977
-367
-16% -$38.5K
MRSH
183
Marsh
MRSH
$90.5B
$204K 0.06%
934
-19
-2% -$4.29K
DSGN icon
184
Design Therapeutics
DSGN
$761M
$204K 0.06%
60,555
+2,277
+4% +$8.52K
PATH icon
185
UiPath
PATH
$6.61B
$204K 0.06%
15,931
-51
-0.3% -$612
BFLY icon
186
Butterfly Network
BFLY
$1.89B
$174K 0.05%
86,920
+2,302
+3% +$5.29K
BWAY
187
Brainsway
BWAY
$611M
$161K 0.05%
24,474
+928
+4% +$4.61K
DFTX
188
Definium Therapeutics
DFTX
$5.78B
$156K 0.05%
24,043
+1,415
+6% +$9.31K
ERAS icon
189
Erasca
ERAS
$6.3B
$153K 0.05%
120,466
+77,135
+178% +$103K
ORGO icon
190
Organogenesis Holdings
ORGO
$305M
$150K 0.05%
41,060
+2,394
+6% +$8.92K
DVAX
191
DELISTED
Dynavax Technologies
DVAX
$149K 0.05%
15,065
-17,332
-53% -$183K
GRCE
192
Grace Therapeutics
GRCE
$33.8M
$144K 0.04%
48,541
+2,534
+6% +$6.74K
CGEM icon
193
Cullinan Oncology
CGEM
$1.01B
$128K 0.04%
17,008
+740
+5% +$5.95K
MDXG icon
194
MiMedx Group
MDXG
$602M
$113K 0.03%
18,435
-5,330
-22% -$35.4K
ELEV
195
DELISTED
Elevation Oncology
ELEV
$108K 0.03%
295,328
+17,326
+6% +$5.78K
VTYX
196
DELISTED
Ventyx Biosciences
VTYX
$58.4K 0.02%
27,270
+772
+3% +$1.25K
NAUT icon
197
Nautilus Biotechnolgy
NAUT
$124M
$30.2K 0.01%
41,661
+499
+1% +$375
ARDX icon
198
Ardelyx
ARDX
$1.22B
-27,638
Closed -$136K
ASRT
199
DELISTED
Assertio
ASRT
-11,412
Closed -$115K
CRMD icon
200
CorMedix
CRMD
$591M
-46,598
Closed -$287K

Similar funds

Palumbo Wealth Management's Q2 2025 Portfolio in Review

As of Q2 2025, Palumbo Wealth Management held 212 positions worth $323M, up 7.9% from $299M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Palumbo Wealth Management's Q2 2025 filing shows 25 new, 92 increased, 73 reduced and 15 closed positions. Its largest new stake was Advanced Micro Devices: 9,934 shares worth $1.41M. The largest sale was UnitedHealth, an estimated $3.71M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Palumbo Wealth Management's largest Q2 2025 buy was Advanced Micro Devices: 9,934 shares worth $1.41M.
  • Palumbo Wealth Management added most to Amazon in Q2 2025, an estimated $2.19M increase.
  • Palumbo Wealth Management's biggest Q2 2025 reduction was Sprott Physical Gold, cutting an estimated $1.13M.
  • Palumbo Wealth Management fully exited UnitedHealth in Q2 2025, selling an estimated $3.71M.
  • Palumbo Wealth Management's ten largest holdings make up 40% of its $323M portfolio in Q2 2025.
  • Palumbo Wealth Management opened 25 new positions and closed 15 in Q2 2025.
  • Palumbo Wealth Management's portfolio value rose 7.9% quarter-over-quarter to $323M.

Based on Palumbo Wealth Management's 13F filing for Q2 2025, filed 15 Jul 2025.